|
|
|
|
| LEADER |
00832nam a2200205 a 4500 |
| 001 |
895883 |
| 005 |
20171111231336.0 |
| 008 |
140212s2003 gr r 000 0 eng d |
| 040 |
|
|
|a GR-VoPTK
|b gre
|e AACR2
|
| 082 |
|
0 |
|2 22 έκδ.
|a 615.58
|
| 245 |
0 |
0 |
|a Guide to selected cancer chemotherapy regimens and associated adverse events ; [edited by Roy Beveridge..[et al.]
|
| 250 |
|
|
|a 4th ed.
|
| 260 |
|
|
|a Thousand Oaks, CA:
|b Amgen,
|c c2003
|
| 300 |
|
|
|a 262 p. ;
|c 19 cm.
|
| 504 |
|
|
|a Περιέχει βιβλιογραφικές αναφορές.
|
| 650 |
1 |
0 |
|a ΧΗΜΕΙΟΘΕΡΑΠΕΙΑ
|x ΕΓΧΕΙΡΙΔΙΑ ΚΛΠ.
|
| 650 |
1 |
0 |
|a ΚΑΡΚΙΝΟΣ *
|x ΧΗΜΕΙΟΘΕΡΑΠΕΙΑ
|
| 700 |
1 |
|
|a Beveridge, Roy A.
|x ΕΓΧΕΙΡΙΔΙΑ ΚΛΠ.
|
| 710 |
|
|
|a Amgen
|
| 952 |
|
|
|a GR-VoPKT
|b 59cc81db6c5ad13446fdc52f
|c 998a
|d 945l
|e 615.58 GUI
|t 1
|x m
|z Books
|
